South India immunoprophylaxis trial against leprosy: relevance of the findings in the context of trends in leprosy.
Gupte
M D
MD
National Institute of Epidemiology, Chetput, Chennai, India.
D001500:BCG Vaccine / Q000008:administration & dosage*; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003906:Developing Countries; D005260:Female; D006801:Humans; D015994:Incidence; D007194:India / Q000453:epidemiology; D007918:Leprosy / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D008297:Male; D012307:Risk Factors; D014611:Vaccination / Q000379:methods*
D001500:BCG Vaccine; D001428:Bacterial Vaccines; C060596:anti-leprosy vaccine